1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the quarter ended September 30, 2024, no director or executive officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the quarter ended March 31, 2025, no director or executive officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Pacira BioSciences, Inc.
2 unchanged sentences
Exhibit Number Description
−Removed: Employment Agreement, dated April 19, 2012, between the Registrant and Lauren Riker.(1)***
−Removed: Amendment No.
−Removed: 1 to Employment Agreement, dated March 13, 2013, between the Registrant and Lauren Riker.(2)***
−Removed: Amendment No.
−Removed: 2 to Employment Agreement, dated June 30, 2015, between the Registrant and Lauren Riker.* ***
−Removed: Amendment No.
−Removed: 3 to Employment Agreement, dated August 16, 2024, between the Registrant and Lauren Riker.* ***
−Removed: Non-Healthcare Professional Consulting Agreement, effective October 1, 2024, between the Registrant and Charles.
−Removed: Reinhart, III* ***
+Added: Third Amended and Restated Bylaws.
+Added: Settlement Agreement, dated April 7, 2025, by and between Pacira BioSciences, Inc.
+Added: and Pacira Pharmaceuticals, Inc.
+Added: with Fresenius Kabi USA, LLC, eVenus Pharmaceutical Laboratories Inc., and Jiangsu Hengrui Pharmaceuticals Co., Ltd.
+Added: (f/k/a Jiangsu Hengrui Medicine Co., Ltd.).* †† ##
Amended and Restated 2014 Inducement Plan.
6 unchanged sentences
101 The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc.
−Removed: for the quarter ended September 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: for the quarter ended March 31, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets;
(ii) the Condensed Consolidated Statements of Operations;
−Removed: (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income;
+Added: (iii) the Condensed Consolidated Statements of Comprehensive Income;
(iv) the Condensed Consolidated Statements of Stockholders’ Equity;
5 unchanged sentences
*** Denotes management contract or compensatory plan or arrangement.
−Removed: (1) Incorporated by reference to the exhibits to the registrant's Quarterly Report on Form 10-Q, filed on May 9, 2012.
−Removed: (2) Incorporated by reference to the exhibits to the registrant’s Current Report on Form 8-K, filed on March 18, 2013.
+Added: Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K.
+Added: The omitted information (i) is not material and (ii) is the type that the Registrant treats as private or confidential.
+Added: ## Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
+Added: The Company hereby undertakes to supplementally furnish copies of any omitted schedules and exhibits to the Securities and Exchange Commission upon request.
+Added: (1) Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K, filed on March 14, 2025.
+Added: (2) Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.
+Added: (3) Incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.
+Added: (4) Incorporated by reference to Exhibit 10.3 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.
Pacira BioSciences, Inc.
2 unchanged sentences
PACIRA BIOSCIENCES, INC.
−Removed: November 6, 2024 By:
+Added: May 8, 2025 By:
Chief Executive Officer and Director
(Principal Executive Officer)
−Removed: November 6, 2024 By:
+Added: May 8, 2025 By:
Chief Financial Officer
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.